Command Palette

Search for a command to run...

Clinical Trials · NCT02650206

Effect of Liraglutide (Victoza) on Inflammation in Human Adipose Tissue and Blood

CompletedPhase 1Liraglutide (Approved)
Phase
Phase 1
Recruitment status
Completed
Sponsor
Stanford University
Enrollment
56
Start date
Jan 2015
Locations
1 site, United States
Primary endpoint
Macrophage polarization: % M2 macrophages in adipose tissue and peripheral blood according to positivity for cell surface markers (measured by flow cytometry).
View Liraglutide compound reference